Fatih Erbey

534 total citations
42 papers, 338 citations indexed

About

Fatih Erbey is a scholar working on Hematology, Surgery and Oncology. According to data from OpenAlex, Fatih Erbey has authored 42 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 9 papers in Surgery and 8 papers in Oncology. Recurrent topics in Fatih Erbey's work include Hematopoietic Stem Cell Transplantation (6 papers), Blood disorders and treatments (5 papers) and Neutropenia and Cancer Infections (5 papers). Fatih Erbey is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Blood disorders and treatments (5 papers) and Neutropenia and Cancer Infections (5 papers). Fatih Erbey collaborates with scholars based in Türkiye, United States and Canada. Fatih Erbey's co-authors include İbrahim Bayram, Atila Tanyeli, Gülyüz Öztürk, Arzu Akçay, Emine Kocabaş, Tahsin Erman, Göksel Leblebisatan, Emre Alhan, Jeffrey L. Nelson and Şakìr Altunbaşak and has published in prestigious journals such as Liver Transplantation, Pediatric Blood & Cancer and Hormone Research in Paediatrics.

In The Last Decade

Fatih Erbey

39 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatih Erbey Türkiye 10 76 73 60 59 47 42 338
Cihangir Akgün Türkiye 13 55 0.7× 38 0.5× 57 0.9× 39 0.7× 10 0.2× 44 382
Hana Golan Israel 12 46 0.6× 72 1.0× 54 0.9× 64 1.1× 4 0.1× 32 405
Martin Griebel Germany 10 18 0.2× 56 0.8× 31 0.5× 47 0.8× 48 1.0× 12 476
Bengü Demirağ Türkiye 11 21 0.3× 45 0.6× 59 1.0× 34 0.6× 12 0.3× 49 327
Andrew Wade Canada 12 33 0.4× 50 0.7× 45 0.8× 26 0.4× 15 0.3× 39 414
Seiji Noma Japan 11 46 0.6× 46 0.6× 26 0.4× 41 0.7× 32 0.7× 19 365
Paola Muggeo Italy 12 32 0.4× 71 1.0× 94 1.6× 33 0.6× 24 0.5× 40 382
Alexandros Makis Greece 15 215 2.8× 36 0.5× 81 1.4× 24 0.4× 11 0.2× 52 701
D. Knafelz Italy 15 37 0.5× 62 0.8× 164 2.7× 39 0.7× 28 0.6× 49 592
Jeong Ok Hah South Korea 11 49 0.6× 36 0.5× 98 1.6× 46 0.8× 13 0.3× 45 326

Countries citing papers authored by Fatih Erbey

Since Specialization
Citations

This map shows the geographic impact of Fatih Erbey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatih Erbey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatih Erbey more than expected).

Fields of papers citing papers by Fatih Erbey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatih Erbey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatih Erbey. The network helps show where Fatih Erbey may publish in the future.

Co-authorship network of co-authors of Fatih Erbey

This figure shows the co-authorship network connecting the top 25 collaborators of Fatih Erbey. A scholar is included among the top collaborators of Fatih Erbey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatih Erbey. Fatih Erbey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erbey, Fatih, Ebru Yılmaz, Musa Karakükçü, et al.. (2025). Successful Use of Haploidentical HSCT in a Child With Schimke Immuno‐Osseous Dysplasia Who Developed PTLD After Kidney Transplantation. Pediatric Transplantation. 29(8). e70234–e70234.
2.
Semerci, Remziye, et al.. (2024). The quality and content analysis of YouTube videos about chemotherapy for children. Pediatric Blood & Cancer. 71(4). e30865–e30865. 6 indexed citations
3.
5.
Erbey, Fatih, et al.. (2015). Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients. Journal of Pediatric Hematology/Oncology. 37(7). 543–547. 7 indexed citations
6.
Erbey, Fatih, et al.. (2015). Mesenchymal Stem Cell Treatment for Steroid RefractoryGraft‐versus‐Host Disease in Children: A Pilot and First Study from Turkey. Stem Cells International. 2016(1). 1641402–1641402. 26 indexed citations
7.
Erbey, Fatih, Emine Kocabaş, İbrahim Bayram, et al.. (2012). Pediatric invasive mucormycosis cured with high dose liposomal amphotericin B. Tuberkuloz ve Toraks. 60(4). 375–379. 3 indexed citations
8.
Akbayram, Sinan, Murat Doğan, Cihangir Akgün, et al.. (2011). Report of a Non-Hodgkin Lymphoma Case Presenting With Pleural Effusion. Journal of Pediatric Hematology/Oncology. 33(5). e192–e194. 7 indexed citations
9.
Erbey, Fatih, et al.. (2011). Retrospective clinical and laboratory evaluation of children with brucellosis. Pediatrics International. 54(2). 215–218. 14 indexed citations
10.
Erbey, Fatih, İbrahim Bayram, Süreyya Soyupak, & Atila Tanyeli. (2011). Isolated Pulmonary Langerhans Cell Histiocytosis in a 3-Year-old Girl With Atypical Radiologic Findings. Journal of Pediatric Hematology/Oncology. 33(3). 246–247. 2 indexed citations
11.
Bayram, İbrahim, Fatih Erbey, Sevcan Erdem, & Atila Tanyeli. (2011). Brain Natriuretic Peptide Levels in Pediatric Cancer Patients with Febrile Neutropenia. Pediatric Hematology and Oncology. 28(4). 294–298. 3 indexed citations
12.
Erbey, Fatih, İbrahim Bayram, Sema Yılmaz, & Atila Tanyeli. (2010). Meropenem monotherapy as an empirical treatment of febrile neutropenia in childhood cancer patients.. PubMed. 11(1). 123–6. 6 indexed citations
13.
Erbey, Fatih, et al.. (2010). Van Gölü Havzasında 1-18 yaş grubu çocuklarda helicobacter pylori sıklığı. Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection. 4(3). 93–95. 2 indexed citations
14.
Erbey, Fatih, İbrahim Bayram, Süreyya Soyupak, & Atila Tanyeli. (2010). Coexistence of Non-Hodgkin Lymphoma and Cyst Hydatid Disease and Successful Medical Treatment. Journal of Pediatric Hematology/Oncology. 32(7). 574–574. 1 indexed citations
15.
Akbayram, Sinan, Murat Doğan, Cihangir Akgün, et al.. (2010). Use of rituximab in three children with relapsed/refractory Burkitt lymphoma. Targeted Oncology. 5(4). 291–294. 9 indexed citations
16.
Erbey, Fatih, İbrahim Bayram, Sema Yılmaz, et al.. (2010). Fms-like tyrosine kinase 3 mutations in childhood acute leukemias and their association with prognosis.. PubMed. 11(4). 923–7. 11 indexed citations
17.
Erbey, Fatih, İbrahim Bayram, Süreyya Soyupak, & Atila Tanyeli. (2010). Coexistence of Non-Hodgkin's Lymphoma and Cyst Hydatid Disease and Successful Medical Treatment. Journal of Pediatric Hematology/Oncology. 32(6). 524–524. 1 indexed citations
18.
Altunbaşak, Şakìr, et al.. (2009). Evaluation of nine children with reversible posterior encephalopathy syndrome. Neurology India. 57(4). 475–475. 33 indexed citations
19.
Bayram, İbrahim, et al.. (2008). The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy‐related weight loss in children. Pediatric Blood & Cancer. 52(5). 571–574. 37 indexed citations
20.
Erbey, Fatih, et al.. (2005). Cerebrospinal Fluid Shunt Infections in Children. Pediatric Neurosurgery. 41(3). 131–136. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026